New Treatment/Salvage Therapy for PCL - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

New Treatment/Salvage Therapy for PCL (Newly Diagnosed + Veteran PCL)

New Treatment/Salvage Therapy for PCL (Newly Diagnosed + Veteran PCL) image

New Treatment/Salvage Therapy for PCL (Newly Diagnosed + Veteran PCL)

Webinar
event Sep 14, 2021 / 02:00PM - 03:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Veteran PCL Patient, Paul Kleutghen, shares with us more information about new front-line therapy treatment for newly diagnosed PCL as well as salvage therapy for those that might be experiencing a relapse. Let's educate ourselves together about treatment options for this incredibly rare disease. 

Schedule & Agenda

Event panelist Audrey Burton-Bethke
02:00 PM
Introduction
Audrey Burton-Bethke
Audrey welcomes everyone, introduces our featured speaker, and shares the event agenda.
Event panelist Paul Kleutghen
02:05 PM
Presentation
Paul Kleutghen
Paul shares information about new front-line therapy treatment for newly diagnosed PCL and salvage therapy for those who may be experiencing a relapse.
Event panelist Audience
02:35 PM
Q & A
Audience
Paul answers the audience's questions about the presentation and related topics.

Speakers & Moderators

The panelist Paul Kleutghen
Paul Kleutghen

I am a patient diagnosed in 2014 with primary plasma cell leukemia (pPCL), a rare and aggressive variant of multiple myeloma and have been very fortunate to find treatment at the division of Cellular Therapy at the Duke University Cancer Institute. My wife, Vicki, and I have two adult children and a grandson who is the ‘light of my life’. Successful treatment has allowed Vicki and I to do what we love best : traveling the world, albeit it with some extra precautions to keep infections away. My career in the pharmaceutical industry has given me insights that I am currently putting to use as an advocate to lower drug pricing, especially prices for anti-cancer drugs and, very specifically, CAR-T therapies, with recent contributions posted by Health affairs, the Institute for Clinical and Economic Review and the Centers for Medicare and Medicaid Services.

Read Bio
The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Plasma Cell Leukemia group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.